Skip to main content
user-generated· regulatory

UK NHS adds Wegovy pill to obesity treatment formulary by 2027

Given the NHS’s track record of adopting GLP-1-based weight loss treatments, oral Wegovy is likely to be incorporated into obesity management guidelines within 18 months. The pill’s convenience and efficacy in trials make it a compelling alternative to injections for patients resistant to needles.

regulatory · Prediction Market

Implied probability (Yes)
75%
Closes
2027-12-31

More regulatory markets

Browse all regulatory markets →

Loading…